Skip to main content
Clinical Trials/TCTR20220719002
TCTR20220719002
Unknown
Phase 2

Restrictive fluid management and early fluid de-escalation versus usual care In critically ill patients: A feasibility Randomized Controlled Trial.

/A0 sites100 target enrollmentJuly 19, 2022

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Critically ill adult patients with circulatory shock requiring fluid resuscitation or vasopressors
Sponsor
/A
Enrollment
100
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 19, 2022
End Date
March 1, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
/A

Eligibility Criteria

Inclusion Criteria

  • 1\. The patient who is 18 years of age or older
  • 2\. The patient with circulatory shock who need fluid resuscitation or vasopressor
  • 3\. The patient has been in intensive care unit for at least 12 hours but no more than 72 hours

Exclusion Criteria

  • 1\. The patient with hypovolemic shock or hemorrhagic shock
  • 2\. The patient with active bleeding requiring blood transfusion
  • 3\. The patient who has severe AKI (KDIGO stage3\)
  • 4\. The patient who is expected to initiate RRT within 24 hour
  • 5\. The patient who receives chronic RRT (maintenance dialysis or renal transplant)
  • 6\. The patient who needs maintenance fluid therapy (e.g. diabetic ketoacidosis, non\-ketotic coma)
  • 7\. The patient with third space loss from severe ascites, severe burn, or bowel obstruction
  • 8\. Severe hyponatremia (Na \<125mmol/L) or hypernatremia (Na \>155mmol/L)
  • 9\. Congestive heart failure
  • 10\. Decompensated cirrhosis

Outcomes

Primary Outcomes

Not specified

Similar Trials